[Sodium valprovate suppresses autophagy in SH-SY5Y cells via activating miR-34c-5p/ATG4B signaling pathway]

Nan Fang Yi Ke Da Xue Xue Bao. 2018 Dec 30;38(12):1415-1420. doi: 10.12122/j.issn.1673-4254.2018.12.03.
[Article in Chinese]

Abstract

Objective: To investigate the effect of sodium valproate (VPA) on activation of miR-34c-5p/ATG4B signaling pathway and autophagy in SH-SY5Y cells.

Methods: Routinely cultured SH-SY5Y cells were treated with VPA at different doses for 24 h, and the changes in the mRNA levels of ATG4B and miR-34c-5p and the protein expression of ATG4B were assessed using qRTPCR and immunoblotting, respectively. The effect of transfection with a plasmid containing ATG4B promoter on the promoter activity of ATG4B in VPA-treated SH-SY5Y cells was assessed using the reporter gene assay. The stability of ATG4B mRNA was analyzed with qPCR in SH-SY5Y cells treated with VPA alone or with VPA combined with the transcription inhibitor actinomycin D. The expression level of miR-34c-5p was detected using qPCR in SH-SY5Y cells treated with VPA alone or with VPA combined with miR-34c-5p mimics or antagonist, and the role of miR-34c-5p in VPA-induced ATG4B down-regulation was evaluated. The changes in the level of autophagy were evaluated by detecting LC3-Ⅱ expression in the cells after treatment with VPA or VPA combined with miR-34c-5p antagonist.

Results: VPA dose-dependently down-regulated the expression of ATG4B at both the mRNA and protein levels in SH-SY5Y cells. VPA treatment did not significantly affect the promoter activity of ATG4B, but obviously lowered the mRNA stability of ATG4B in SH-SY5Y cells. VPA treatment up-regulated the expression of miR-34c-5p, and the miR-34c-5p antagonist reversed VPA-induced down-regulation of ATG4B in SH-SY5Y cells. VPA also down-regulated the expression level of LC3-Ⅱ in SH-SY5Y cells.

Conclusions: VPA suppresses autophagy in SH-SY5Y cells possibly via activating miR-34c-5p/ATG4B signaling pathway.

目的: 探讨丙戊酸钠(VPA)对SH-SY5Y细胞中miR-34c-5p/ATG4B信号通路的激活作用及对自噬的影响。

方法: 人神经母细胞瘤细胞SH-SY5Y用含10%胎牛血清的DMEM培养基常规培养,然后使用不同剂量VPA处理SH-SY5Y细胞24 h,采用定量PCR分析VPA处理对ATG4B mRNA与miR-34c-5p表达的影响,免疫印迹法分析VPA处理对ATG4B蛋白表达的影响,将含ATG4B启动子片段的报告质粒转染SH-SY5Y细胞,然后通过荧光素酶报告基因系统分析VPA处理对ATG4B启动子活性的影响,用VPA单独或联合转录抑制剂放线菌素D分别处理SH-SY5Y细胞不同时间,定量PCR分析检测不同处理对ATG4B mRNA稳定性的影响,用VPA单独或联合miR-34c-5p抑制剂处理细胞24 h,通过检测不同处理对ATG4B表达变化的影响,进而判断miR-34c-5p在VPA下调ATG4B表达中的作用,同时通过Western blot检测不同处理对LC3-Ⅱ表达的影响,分析细胞自噬水平变化。

结果: VPA可剂量依赖性降低SH-SY5Y细胞中ATG4B的mRNA和蛋白水平(P < 0.05)。VPA处理不影响SHSY5Y细胞中ATG4B的启动子活性(P>0.05),但显著下调其mRNA的稳定性(P < 0.05)。同时,VPA处理明显增强SH-SY5Y细胞中miR-34c-5p的表达水平(P < 0.05)。使用miR-34c-5p抑制剂与VPA联合处理SH-SY5Y细胞,可逆转VPA对ATG4B表达的下调作用。VPA处理还下调了SH-SY5Y细胞中LC3-Ⅱ的表达水平(P < 0.05)。

结论: 结论VPA可能通过激活miR-34c-5p/ATG4B信号通路而抑制SH-SY5Y细胞自噬。

Keywords: ATG4B; SH-SY5Y cells; autophagy; miR-34c-5p; sodium valproate.

MeSH terms

  • Autophagy / drug effects*
  • Autophagy-Related Proteins / genetics
  • Autophagy-Related Proteins / metabolism*
  • Cell Line
  • Cysteine Endopeptidases / genetics
  • Cysteine Endopeptidases / metabolism*
  • Dactinomycin / pharmacology
  • Down-Regulation
  • Genes, Reporter
  • Humans
  • MicroRNAs / antagonists & inhibitors
  • MicroRNAs / metabolism*
  • Microtubule-Associated Proteins / metabolism
  • RNA, Messenger / metabolism
  • Signal Transduction / drug effects
  • Transfection
  • Valproic Acid / administration & dosage
  • Valproic Acid / antagonists & inhibitors
  • Valproic Acid / pharmacology*

Substances

  • Autophagy-Related Proteins
  • MAP1LC3B protein, human
  • MIRN34 microRNA, human
  • MicroRNAs
  • Microtubule-Associated Proteins
  • RNA, Messenger
  • Dactinomycin
  • Valproic Acid
  • ATG4A protein, human
  • Cysteine Endopeptidases

Grants and funding

国家自然科学基金青年科学基金(31201068);重庆市特殊儿童心理诊断与教育技术实验室重点项目(201711000251)